CN116159105A - 一种治疗痔疮的药物组合物 - Google Patents
一种治疗痔疮的药物组合物 Download PDFInfo
- Publication number
- CN116159105A CN116159105A CN202310313591.7A CN202310313591A CN116159105A CN 116159105 A CN116159105 A CN 116159105A CN 202310313591 A CN202310313591 A CN 202310313591A CN 116159105 A CN116159105 A CN 116159105A
- Authority
- CN
- China
- Prior art keywords
- parts
- hemorrhoids
- composition
- pharmaceutical composition
- liquorice
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000014617 hemorrhoid Diseases 0.000 title claims abstract description 77
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 17
- 239000000203 mixture Substances 0.000 claims abstract description 57
- 239000003814 drug Substances 0.000 claims abstract description 54
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 21
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 21
- 244000274050 Platycodon grandiflorum Species 0.000 claims abstract description 20
- 235000006753 Platycodon grandiflorum Nutrition 0.000 claims abstract description 20
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 20
- 235000011477 liquorice Nutrition 0.000 claims abstract description 20
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 18
- 241000972673 Phellodendron amurense Species 0.000 claims abstract description 12
- 240000004534 Scutellaria baicalensis Species 0.000 claims abstract description 12
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims abstract description 12
- 241000037740 Coptis chinensis Species 0.000 claims abstract description 11
- 240000004980 Rheum officinale Species 0.000 claims abstract description 11
- 235000008081 Rheum officinale Nutrition 0.000 claims abstract description 11
- 229910052602 gypsum Inorganic materials 0.000 claims abstract description 11
- 239000010440 gypsum Substances 0.000 claims abstract description 11
- 238000002347 injection Methods 0.000 claims description 29
- 239000007924 injection Substances 0.000 claims description 29
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 19
- 241001106477 Paeoniaceae Species 0.000 claims description 17
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 16
- 229940002612 prodrug Drugs 0.000 claims description 15
- 239000000651 prodrug Substances 0.000 claims description 15
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 14
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 11
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 11
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 11
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 11
- 240000006079 Schisandra chinensis Species 0.000 claims description 11
- 244000126002 Ziziphus vulgaris Species 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- 244000111489 Gardenia augusta Species 0.000 claims description 10
- 235000006533 astragalus Nutrition 0.000 claims description 10
- 241000132012 Atractylodes Species 0.000 claims description 9
- 235000008422 Schisandra chinensis Nutrition 0.000 claims description 9
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 claims description 8
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims description 8
- 229930003451 Vitamin B1 Natural products 0.000 claims description 8
- 235000006545 Ziziphus mauritiana Nutrition 0.000 claims description 8
- 235000008529 Ziziphus vulgaris Nutrition 0.000 claims description 8
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 claims description 8
- 229960003022 amoxicillin Drugs 0.000 claims description 8
- 229960001680 ibuprofen Drugs 0.000 claims description 8
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 8
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 8
- 229960003495 thiamine Drugs 0.000 claims description 8
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 8
- 239000011691 vitamin B1 Substances 0.000 claims description 8
- 235000010374 vitamin B1 Nutrition 0.000 claims description 8
- 230000001919 adrenal effect Effects 0.000 claims description 7
- 235000011187 glycerol Nutrition 0.000 claims description 7
- 241000045403 Astragalus propinquus Species 0.000 claims description 6
- 241000007126 Codonopsis pilosula Species 0.000 claims description 5
- 239000009705 sanhuang Substances 0.000 claims description 3
- 244000299790 Rheum rhabarbarum Species 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 abstract description 17
- 201000010099 disease Diseases 0.000 abstract description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 5
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 2
- 240000001972 Gardenia jasminoides Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 32
- 229940079593 drug Drugs 0.000 description 20
- 235000019640 taste Nutrition 0.000 description 12
- 239000002775 capsule Substances 0.000 description 11
- 230000000740 bleeding effect Effects 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 9
- 238000010926 purge Methods 0.000 description 9
- 230000001717 pathogenic effect Effects 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 241000219061 Rheum Species 0.000 description 7
- 210000000436 anus Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000012286 potassium permanganate Substances 0.000 description 7
- 230000001105 regulatory effect Effects 0.000 description 7
- 241000756943 Codonopsis Species 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 230000001954 sterilising effect Effects 0.000 description 6
- 231100000419 toxicity Toxicity 0.000 description 6
- 230000001988 toxicity Effects 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 5
- 241001061264 Astragalus Species 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 208000005392 Spasm Diseases 0.000 description 4
- 238000005469 granulation Methods 0.000 description 4
- 230000003179 granulation Effects 0.000 description 4
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 210000004233 talus Anatomy 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 230000002439 hemostatic effect Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 235000019633 pungent taste Nutrition 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 239000009636 Huang Qi Substances 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 238000007596 consolidation process Methods 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 150000007857 hydrazones Chemical class 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 235000019614 sour taste Nutrition 0.000 description 2
- 235000021259 spicy food Nutrition 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 235000019605 sweet taste sensations Nutrition 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 244000183685 Citrus aurantium Species 0.000 description 1
- 235000007716 Citrus aurantium Nutrition 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 229920002752 Konjac Polymers 0.000 description 1
- 244000236658 Paeonia lactiflora Species 0.000 description 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 description 1
- 208000037062 Polyps Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000035999 Recurrence Diseases 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000021196 dietary intervention Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 235000010485 konjac Nutrition 0.000 description 1
- 239000010271 massa medicata fermentata Substances 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 235000021110 pickles Nutrition 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 210000001631 vena cava inferior Anatomy 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8964—Anemarrhena
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗痔疮的药物组合物,属于中药技术领域。其包括一期组合物,按照质量份数计,所述一期组合物包括8~12份的黄连、13~17份的黄芩、13~17份的黄柏、25~35份的石膏、13~17份的知母、13~17份的栀子、13~17份的白芍、13~17份的桔梗、13~17份的枳壳、13~17份的建曲、10~14份的大黄、8~12份的甘草。本发明具有能够有效改善患者的痔疮情况,从病因出发,在解决病因的同时促进机体解毒排脓,标本兼治,以消除皮辨、治愈痔疮的优点。
Description
技术领域
本发明涉及一种治疗痔疮的药物组合物,属于中药技术领域。
背景技术
人体肛门部有丰富的静脉丛,当人体受到外界风寒湿侵袭时,在下腔静脉丛扩张发生的一种皮辨叫痔,即痔疮。根据生长位置的不同,痔疮分为内痔、外痔和混合痔,生长在齿状线以上的叫内痔,生长在齿状线以下的叫外痔,上下都有的叫混合痔,生长于直肠壁的叫息肉痔。同时,痔疮在肛门边缘随处可生,根据时钟方向的位置分为1-12点痔。结合病程和临床表现,痔疮有早期症状、中期症状和晚期症状,其中,早期的痔疮没有任何感觉,不痛不胀不痒,只是稍有皮辨;中期皮辨逐渐长大,长期大便秘结,吃了辛辣造火的食物或过量饮酒、吸烟后疼痛加剧。个别内痔会产生出血点,多是大便带血,常有内痔脱出肛外,但大便后可自行回收。患者在早、中期没有得到正确的治疗时,病程发展至晚期,痔疮可随时脱出肛外,常有出血,脱出后不能自行回收,且伴随有严重疼痛感。
对于痔疮的治疗,分为保守治疗、门诊手术治疗和外科手术治疗,其中,保守治疗方案包括饮食干预、生活方式的改变和药物治疗,但用于治疗的药物无法针对病程的不同时期,难以在短时间内快速实现痊愈。
发明内容
本发明的目的在于克服现有技术的不足,提供一种治疗痔疮的药物组合物。
本发明的提供一种治疗痔疮的药物组合物,包括一期组合物,按照质量份数计,所述一期组合物包括8~12份的黄连、13~17份的黄芩、13~17份的黄柏、25~35份的石膏、13~17份的知母、13~17份的栀子、13~17份的白芍、13~17份的桔梗、13~17份的枳壳、13~17份的建曲、10~14份的大黄、8~12份的甘草。
一期组合物以黄芩、黄连、黄柏和石膏、知母相配,能够去火邪、清气分热、润肠燥,辅以栀子和大黄,以提高其清热泻火、凉血解毒的功效,配以白芍和桔梗,改善其解毒排脓的功效,再佐以枳壳、建曲和甘草,行气宽中,调和诸药药性,以实现对痔疮的治疗效果,消除皮辨,促进痔疮痊愈。具体来说,一期组合物中:
黄芩,味苦、性寒,有清热燥湿、泻火解毒、止血和安胎的功效,黄连,亦味苦、性寒,有清热燥湿、泻火解毒的功效,黄柏,味苦、性寒,有清热燥湿、泻火除蒸、解毒疗疮的功效,黄芩、黄连和黄柏三者复配,清三焦湿热,能够泄火解毒。石膏,味甘、辛,性大寒,生用有清热泻火、除烦止渴的功效,知母,味苦、性寒,具有清热泻火、滋阴润燥的功效,石膏与知母配合,能够清气分热,且对肠燥便秘有治疗效果。
栀子,味苦、性寒,具有泻火除烦、清热利湿、凉血解毒的功效,大黄,味苦、性寒,具有泻下功积、清热泻火、凉血解毒、逐瘀通经的效果,两者配合黄芩、黄连、黄柏和石膏知母,增强其清热泻火除湿功效。
白芍,味甘、辛,性温,具有祛风除湿、解毒镇痉的功效,桔梗,味苦、辛,性平,具有宣肺、利咽、祛痰和排脓的功效,可与黄柏配合,提高其解毒排脓效果。
枳壳,味苦、辛、酸,性微寒,具有理气宽中、行滞消胀的功效,建曲,气清香,味微,具有解表和中的功效,甘草,味甘、性平,具有补脾益气、清热解毒、祛痰止咳、缓急止痛、调和诸药的功效,三者配合改善和调和诸药药性。
进一步的,按照质量份数计,所述一期组合物包括9~11份的黄连、14~16份的黄芩、14~16份的黄柏、28~32份的石膏、14~16份的知母、14~16份的栀子、14~16份的白芍、14~16份的桔梗、14~16份的枳壳、14~16份的建曲、11~13份的大黄、9~11份的甘草。
进一步的,还包括二期组合物,按照质量份数计,所述二期组合物包括13~17份的党参、16~20份的黄芪、13~17份的白及、13~17份的白术、13~17份的桔梗、13~17份的木香、13~17份的山药、13~17份的五味子、13~17份的白芍、13~17份的枳壳、13~17份的建曲、13~17份的大枣、8~12份的甘草。在对痔疮患者的治疗中,通过服用一期组合物的药物,促进痔疮变色脱落,在痔疮脱落后,可继续服用二期组合物进行治疗巩固。
二期组合物以党参、黄芪复配白及,补中益气,收敛生肌,以帮助帮助患者快速恢复,修复病灶。配合桔梗、白术和白芍,促进祛湿排脓,再结合木香、枳壳和建曲,行气和中。山药和五味子有助于组合物将药效引向病灶,大枣和甘草则调和药性、解药毒。具体来说,一期组合物中:
党参,味甘,性平,具有补中、益气、生津的功效,黄芪,味甘,性微温,具有健脾补中、升阳举陷、益卫固表、利尿、托毒生肌的效果,两者共同发挥补中益气的作用。白及,味苦、甘、涩,性微寒,具有收敛止血、消肿生肌的效果,配合黄芪增强生肌效果。
白术,味苦、甘,性温,具有健脾益气、燥湿利水、止汗、安胎的功效,提高补中益气的作用,同时发挥燥湿功效。桔梗,味苦、辛,性平,具有宣肺、利咽、祛痰和排脓的功效,白芍,味甘、辛,性温,具有祛风除湿、解毒镇痉的功效,配合白术祛湿排脓。
木香,味辛、苦,性温,具有行气止痛、健脾消食的功效,枳壳,味苦、辛、酸,性微寒,具有理气宽中、行滞消胀的功效,建曲,气清香,味微,具有解表和中的功效。山药,味甘,性温,具有健脾、补肺、固肾、益精的功效,五味子,味酸、甘,性温,具有收敛固涩、益气生津、补肾宁心的功效,大枣,味甘,性平,具有补脾和胃、益气生津、调营卫、解药毒的功效。甘草,味甘、性平,具有补脾益气、清热解毒、祛痰止咳、缓急止痛、调和诸药的功效。
进一步的,按照质量份数计,所述二期组合物包括14~16份的党参、17~19份的黄芪、14~16份的白及、14~16份的白术、14~16份的桔梗、14~16份的木香、14~16份的山药、14~16份的五味子、14~16份的白芍、14~16份的枳壳、14~16份的建曲、14~16份的大枣、9~11份的甘草。
进一步的,还包括前期药物,所述前期药物包括三黄片、大黄碳酸氢钠片、维生素B1、布洛芬和阿莫西林。在治疗初期,可先采用前期药物复配,缓解症状、控制病势。
进一步的,所述前期药物还包括肾上腺血腙片。对于出血量多的患者,在前期药物中增加肾上腺血腙片以改善出血情况。
进一步的,还包括注射用药物,按照体积份数计,所述注射用药物包括1.5~2.5份的甘油、1.5~2.5份的95%酒精和2.5~3.5份的石碳酸。即以甘油、酒精和苯酚作为注射用药物复配,治疗时注入痔疮与肌肉平衡的三分之一处痔核中,在佐以前期药物、一期药物和二期药物,分阶段服用,能够快速治愈痔疮,使患者得到根治不再复发。
本发明的有益效果是:
1)通过采用一期组合物对痔疮患者进行治疗,能够有效改善患者的痔疮情况,从病因出发,在解决病因的同时促进机体解毒排脓,标本兼治,以达到消除皮辨、治愈痔疮的目的。
2)通过采用二期组合物与一期组合物衔接治疗痔疮,在患者的痔疮变色脱落后,更换二期组合物作为服用药物,能够有效促进患者机体的调节和恢复,避免复发。
3)采用注射用药物、前期药物、一期组合物和二期组合物复配,先对患处注射注射用药物,并同步服用前期药物,在服用3-5天后,更换一期组合物,清楚病根,待痔疮脱落后,再更换二期组合物,彻底除去病根,帮助和促进机体快速恢复健康、重新建立平衡,使患者治愈后不再复发,无任何后遗症。本发明的药物组合物配合使用,对患者的治愈率高达98%以上。
具体实施方式
下面将结合实施例,对本发明的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域技术人员在没有付出创造性劳动的前提下所获得的所有其他实施例,都属于本发明保护的范围。实施例中未注明具体条件者,按照常规条件或制造商建议的条件进行。所用试剂或仪器未注明生产厂商者,均为可以通过市售购买获得的常规产品。
本发明提供一种治疗痔疮的药物组合物,包括一期组合物,按照质量份数计,所述一期组合物包括8~12份的黄连、13~17份的黄芩、13~17份的黄柏、25~35份的石膏、13~17份的知母、13~17份的栀子、13~17份的白芍、13~17份的桔梗、13~17份的枳壳、13~17份的建曲、10~14份的大黄、8~12份的甘草。
优选的,按照质量份数计,所述一期组合物包括9~11份的黄连、14~16份的黄芩、14~16份的黄柏、28~32份的石膏、14~16份的知母、14~16份的栀子、14~16份的白芍、14~16份的桔梗、14~16份的枳壳、14~16份的建曲、11~13份的大黄、9~11份的甘草。
本发明的药物组合物还包括二期组合物,按照质量份数计,所述二期组合物包括13~17份的党参、16~20份的黄芪、13~17份的白及、13~17份的白术、13~17份的桔梗、13~17份的木香、13~17份的山药、13~17份的五味子、13~17份的白芍、13~17份的枳壳、13~17份的建曲、13~17份的大枣、8~12份的甘草。在对痔疮患者的治疗中,通过服用一期组合物的药物,促进痔疮变色脱落,在痔疮脱落后,可继续服用二期组合物进行治疗巩固。
优选的,按照质量份数计,所述二期组合物包括14~16份的党参、17~19份的黄芪、14~16份的白及、14~16份的白术、14~16份的桔梗、14~16份的木香、14~16份的山药、14~16份的五味子、14~16份的白芍、14~16份的枳壳、14~16份的建曲、14~16份的大枣、9~11份的甘草。
本发明的药物组合物还包括前期药物,所述前期药物包括三黄片、大黄碳酸氢钠片、维生素B1、布洛芬和阿莫西林。这些药物均为成熟的中成药或西药,可在市面上直接购买得到相应的片剂或胶囊剂,按相关药物说明组合服用即可。优选的,在服用一期组合物前,按照市售药常见规格:三黄片2片、大黄碳酸氢钠片3片、维生素B1片2片、布洛芬胶囊1粒、阿莫西林胶囊(0.25g)2粒的组合服用,一日三次,连续服用5天。
进一步的,所述前期药物还包括肾上腺血腙片。对于出血量多的患者,在前期药物中增加肾上腺血腙片2片。
本发明的药物组合物还包括注射用药物,按照体积份数计,所述注射用药物包括1.5~2.5份的甘油、1.5~2.5份的95%酒精和2.5~3.5份的石碳酸。用药前,可将注射用药物按上述份数比例复配混合均匀,加盖并用蜡封口后备用。在对患处消毒后注射上述注射用药物,注射量以痔核的大小而定,以注射至痔疮变色为准。
实施例一
患者周某,男,52岁,患晚期内痔,为3、5、6、8、9、10点痔,就诊检查发现,出血严重,有6个痔疮长期脱出肛外,小的约2厘米,大的约7厘米。治疗前先用高锰酸钾溶液对患处进行消毒,再采用75%酒精消毒,然后采用注射用药物,具体为:注射用药物由2mL甘油、2mL95%酒精和3mL石碳酸组成,混合均匀后取用,采用1ml空针抽取注射用药物,最小处用0.2mL,最大处用0.8mL,分别在肛门肌肉平衡三分之一痔疮正中处注射给药。出针后用止血钳夹住针孔,六个痔疮共计用药3.5mL,注射完成10min后再次采用高锰酸钾溶液对痔疮进行消毒,让患者卧床休息。同时给口服前期药物:三黄片2片、大黄碳酸氢钠片3片、维生素B1片2片、布洛芬胶囊1粒、阿莫西林胶囊(0.25g)2粒和肾上腺血腙片2片,一日服用三次,连续服药5天。采用一期组合物:10g的黄连、15g的黄芩、15g的黄柏、30g的石膏、15g的知母、15g的栀子、15g的白芍、15g的桔梗、15g的枳壳、15g的建曲、12g的大黄和10g的甘草,对一期组合物煎服,一日三次,连服三剂。采用注射用药物后第二天复查,对6、9、10点痔进行补药,补药次日复查,痔疮已全部变成黑色,停止注射用药物的用药。服用前期药物的第四天,痔疮开始脱落,同时有大量分泌物和臭味。自第一次采用注射用药物的第九天,痔疮已全部掉完,更换药物为二期组合物:15g的党参、18g的黄芪、15g的白及、15g的白术、15g的桔梗、15g的木香、15g的山药、15g的五味子、15g的白芍、15g的枳壳、15g的建曲、15g的大枣和10g的甘草,对二期组合物煎服,一日三次,连服三剂。服用完成后自行调养,服药期间,大便后用高锰酸钾溶液消毒,生活禁忌吃魔芋、牛肉、泡菜、血、辛辣食物、烟、酒,严禁干重体力活,严禁乘坐摩托车、三轮车,尽量吃流食,少吃多餐,保持大便通畅,严禁性生活。八周后复查,患者已完全痊愈,未见复发。
实施例二
患者李某,男,32岁,检查发现外痔3个,分别为4、6、8点痔,最小的约3cm,最大的约6cm。治疗前先用高锰酸钾溶液对患处进行消毒,再采用75%酒精消毒,然后采用注射用药物,具体为:注射用药物由2mL甘油、2mL95%酒精和3mL石碳酸组成,混合均匀后取用,采用1ml空针抽取注射用药物。出针后用止血钳夹住针孔,注射完成10min后再次采用高锰酸钾溶液对痔疮进行消毒,让患者卧床休息。同时给口服前期药物:三黄片2片、大黄碳酸氢钠片3片、维生素B1片2片、布洛芬胶囊1粒和阿莫西林胶囊(0.25g)2粒,一日服用三次,连续服药5天。采用一期组合物:10g的黄连、15g的黄芩、15g的黄柏、30g的石膏、15g的知母、15g的栀子、15g的白芍、15g的桔梗、15g的枳壳、15g的建曲、12g的大黄和10g的甘草,对一期组合物煎服,一日三次,连服三剂。采用注射用药物后第二天复查,三个痔疮已全部变成黑色,停止注射用药物的用药。服用前期药物的第五天,痔疮开始脱落,患者有疼痛感。自第一次采用注射用药物的第十二天,痔疮已全部掉完,更换药物为二期组合物:15g的党参、18g的黄芪、15g的白及、15g的白术、15g的桔梗、15g的木香、15g的山药、15g的五味子、15g的白芍、15g的枳壳、15g的建曲、15g的大枣和10g的甘草,对二期组合物煎服,一日三次,连服三剂。服用完成后自行调养,服药期间的医嘱禁忌同实施例一,六周后复查,患者已完全痊愈,未见复发。
实施例三
患者何某,女,51岁,患晚期混合痔,为3、4、5、6、8、9、10点痔,小的约2cm,大的约7cm ,共计7个,有出血点。治疗前先用高锰酸钾溶液对患处进行消毒,再采用75%酒精消毒,然后采用注射用药物,具体为:注射用药物由2mL甘油、2mL95%酒精和3mL石碳酸组成,混合均匀后取用,采用1ml空针抽取注射用药物。出针后用止血钳夹住针孔,七个痔疮共计用药8mL,注射完成10min后再次采用高锰酸钾溶液对痔疮进行消毒,让患者卧床休息。同时给口服前期药物:三黄片2片、大黄碳酸氢钠片3片、维生素B1片2片、布洛芬胶囊1粒、阿莫西林胶囊(0.25g)2粒和肾上腺血腙片2片,一日服用三次,连续服药5天。采用一期组合物:10g的黄连、15g的黄芩、15g的黄柏、30g的石膏、15g的知母、15g的栀子、15g的白芍、15g的桔梗、15g的枳壳、15g的建曲、12g的大黄和10g的甘草,对一期组合物煎服,一日三次,连服三剂。采用注射用药物后第二天复查,对6、8、10点痔进行补药,十日后复查另发现一个3点痔,约1cm大,注射0.2mL的注射用药物,采用二期组合物:15g的党参、18g的黄芪、15g的白及、15g的白术、15g的桔梗、15g的木香、15g的山药、15g的五味子、15g的白芍、15g的枳壳、15g的建曲、15g的大枣和10g的甘草,对二期组合物煎服,一日三次,连服六剂。20天后复查,再次发现一个七点痔,约2cm大,再次补注射用药物0.3mL。后再次服用前期药物:三黄片2片、大黄碳酸氢钠片3片、维生素B1片2片、布洛芬胶囊1粒和阿莫西林胶囊(0.25g)2粒,一日服用三次,连续服药5天。服药期间的医嘱禁忌同实施例一,九周后复查,患者已完全痊愈,未见复发。
除上述几个具体实施例外,本发明的药物组合物前后治愈了八百多例病患,治愈效果达到98以上,可实现根治痊愈后不复发,无任何后遗症。
以上所述仅是本发明的优选实施方式,应当理解本发明并非局限于本文所披露的形式,不应看作是对其他实施例的排除,而可用于各种其他组合、修改和环境,并能够在本文所述构想范围内,通过上述教导或相关领域的技术或知识进行改动。而本领域人员所进行的改动和变化不脱离本发明的精神和范围,则都应在本发明所附权利要求的保护范围内。
Claims (7)
1.一种治疗痔疮的药物组合物,其特征在于:包括一期组合物,按照质量份数计,所述一期组合物包括8~12份的黄连、13~17份的黄芩、13~17份的黄柏、25~35份的石膏、13~17份的知母、13~17份的栀子、13~17份的白芍、13~17份的桔梗、13~17份的枳壳、13~17份的建曲、10~14份的大黄、8~12份的甘草。
2.根据权利要求1所述的一种治疗痔疮的药物组合物,其特征在于:按照质量份数计,所述一期组合物包括9~11份的黄连、14~16份的黄芩、14~16份的黄柏、28~32份的石膏、14~16份的知母、14~16份的栀子、14~16份的白芍、14~16份的桔梗、14~16份的枳壳、14~16份的建曲、11~13份的大黄、9~11份的甘草。
3.根据权利要求1或2所述的一种治疗痔疮的药物组合物,其特征在于:还包括二期组合物,按照质量份数计,所述二期组合物包括13~17份的党参、16~20份的黄芪、13~17份的白及、13~17份的白术、13~17份的桔梗、13~17份的木香、13~17份的山药、13~17份的五味子、13~17份的白芍、13~17份的枳壳、13~17份的建曲、13~17份的大枣、8~12份的甘草。
4.根据权利要求3所述的一种治疗痔疮的药物组合物,其特征在于:按照质量份数计,所述二期组合物包括14~16份的党参、17~19份的黄芪、14~16份的白及、14~16份的白术、14~16份的桔梗、14~16份的木香、14~16份的山药、14~16份的五味子、14~16份的白芍、14~16份的枳壳、14~16份的建曲、14~16份的大枣、9~11份的甘草。
5.根据权利要求1所述的一种治疗痔疮的药物组合物,其特征在于:还包括前期药物,所述前期药物包括三黄片、大黄碳酸氢钠片、维生素B1、布洛芬和阿莫西林。
6.根据权利要求5所述的一种治疗痔疮的药物组合物,其特征在于:所述前期药物还包括肾上腺血腙片。
7.根据权利要求1所述的一种治疗痔疮的药物组合物,其特征在于:还包括注射用药物,按照体积份数计,所述注射用药物包括1.5~2.5份的甘油、1.5~2.5份的95%酒精和2.5~3.5份的石碳酸。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310313591.7A CN116159105A (zh) | 2023-03-28 | 2023-03-28 | 一种治疗痔疮的药物组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310313591.7A CN116159105A (zh) | 2023-03-28 | 2023-03-28 | 一种治疗痔疮的药物组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116159105A true CN116159105A (zh) | 2023-05-26 |
Family
ID=86422122
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310313591.7A Pending CN116159105A (zh) | 2023-03-28 | 2023-03-28 | 一种治疗痔疮的药物组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116159105A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1493348A (zh) * | 2003-09-04 | 2004-05-05 | 伟 邓 | 复方痔瘘丸药 |
CN101897893A (zh) * | 2009-11-24 | 2010-12-01 | 王春鹏 | 八味痔疮散 |
CN102441134A (zh) * | 2011-12-08 | 2012-05-09 | 张学忠 | 中草药组合物、制剂及其制备方法和应用 |
-
2023
- 2023-03-28 CN CN202310313591.7A patent/CN116159105A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1493348A (zh) * | 2003-09-04 | 2004-05-05 | 伟 邓 | 复方痔瘘丸药 |
CN101897893A (zh) * | 2009-11-24 | 2010-12-01 | 王春鹏 | 八味痔疮散 |
CN102441134A (zh) * | 2011-12-08 | 2012-05-09 | 张学忠 | 中草药组合物、制剂及其制备方法和应用 |
Non-Patent Citations (2)
Title |
---|
定州市中医医院: "注射治痔,一针见效!", pages 2, Retrieved from the Internet <URL:https://mp.weixin.qq.com/s?src=11×tamp=1705474222&ver=5023&signature=c18pGIXY3EdWiNzYcXSzxY1CShTqZptSIAQ9uc-LZpAEgfmaD0PqTmUdhLMrbH9iBP6PnVYCdNSOpYog7TfxdTcKAEzLHfO0cbrwQZHTpSt0XYW7USn*gN7jdUt4Lzmn&new=1> * |
王新陆: "《实用老年中医学》", 31 October 2010, 华龄出版社, pages: 259 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100493599C (zh) | 一种内服治疗慢性肠炎的中药组合物 | |
CN102188685A (zh) | 一种治疗腹泻型肠易激综合征中药外敷散剂及其制备方法 | |
CN104189783A (zh) | 一种治疗口腔溃疡的中药 | |
CN101766787B (zh) | 治疗高热、咳喘的灌肠液 | |
CN104840695A (zh) | 一种用于治疗仔猪白痢的药物组合物及其制备方法 | |
CN104873926A (zh) | 治疗腹泻的中药制剂及其制备方法与应用 | |
CN104524481A (zh) | 一种治疗肠易激综合征的中药及其制备方法 | |
CN104524275A (zh) | 一种促进膀胱癌术后恢复的中药片剂及其制备方法 | |
CN104547048A (zh) | 一种预防并治疗小儿手足口病的中药复方制剂及其制备方法 | |
CN116159105A (zh) | 一种治疗痔疮的药物组合物 | |
CN113616758A (zh) | 一种药物外敷治疗儿童功能性便秘的中医药适宜技术 | |
CN106421053A (zh) | 一种健脾暖胃的中药 | |
CN105343578A (zh) | 一种治疗痔疮的药物组合物 | |
CN105521332A (zh) | 治疗肛裂的中药组合物及其制备方法和应用 | |
CN105412621A (zh) | 一种制备治疗痔疮的药物组合物的方法 | |
CN105233208A (zh) | 一种治疗心力衰竭的中药制剂 | |
CN105126000A (zh) | 一种治疗小儿湿疹的外用药膏 | |
CN104524531A (zh) | 用于治疗放射性直肠炎的中药组合物及制备方法 | |
CN104623381A (zh) | 一种用于治疗血热肝郁所致的皮肤病的中药组合物 | |
CN103610934A (zh) | 一种治疗咽炎的中药 | |
CN103495130A (zh) | 一种用于治疗气喘的中药组合物 | |
CN108653572A (zh) | 一种治疗便秘的中药口服剂及制备方法 | |
CN102240384B (zh) | 一种治疗痰瘀互结型癫痫的药物及其制备方法 | |
CN105412392A (zh) | 一种治疗痔疮的中药组合物及其制备方法 | |
CN106620266A (zh) | 一种治疗猪气喘病的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |